Jul 2026· Current opinion in pediatrics· 0 citations· 50 references
Medicine
TL;DR
Overall, AI is being applied to pediatric genomics in many different ways, including: identifying individuals who may have genetic conditions and assisting in the diagnostic process; AI implementation in the laboratory-based genetic testing process; and how recent AI developments may support patient management as well as discovery and research into novel ways to treat genetic conditions.
Abstract
Purpose
OF REVIEW
Artificial intelligence (AI) is being rapidly but unevenly integrated into many aspects of medicine as well as society more broadly. This review focuses on recent developments in AI through the lens of how it is affecting the field of pediatric genomics.
RECENT
Findings
This article describes and explains general definitions of AI and its subtypes, including related to the latest AI applications. The article then outlines ways in which AI is being used and tested in multiple aspects of pediatric genomics, including: identifying individuals who may have genetic conditions and assisting in the diagnostic process; AI implementation in the laboratory-based genetic testing process; how recent AI developments may support patient management as well as discovery and research into novel ways to treat genetic conditions. Overall, AI is being applied to pediatric genomics in many different ways.
SUMMARY
The field of pediatrics will undergo dramatic change because of AI. This piece traces different ways in which AI may affect one particular field, pediatric genomics. Due to rapid advances, it is likely that future AI discoveries will lead to additional ways in which AI affects this field.
The present study delves into the significant contributions that artificial intelligence (AI) has made to the field of cancer, and specifically highlights the applications of AI in diagnosis, personalized treatment, and clinical trial optimization.
{"name":"Y. Ismail","email":"ismailcsp@crescent.education","af, {"name":"F. Yasirahsabreen","email":"ismailcsp@crescent.educat· Future Journal of Pharmaceut...· 0 citations
Artificial intelligence (AI) is increasingly being explored as a bridge between high-dimensional cardiovascular phenotyping and genomic interpretation in children with inherited and congenital heart disease. This review focuses specifically on where AI-assisted approaches in pediatric cardiovascular genetics have progr...
Nikola Ilić, S. Krasic, V. Vukomanovic et al.· International Journal of Mol...· 0 citations
This review evaluates the current state of AI applications in medicine, focusing on clinical knowledge encoding, molecular drug discovery, and administrative workflow optimization, while critically addressing the technical, ethical, and systemic challenges of their institutional implementation.
Aleksandra Stańczyk, Kinga Haduch, Zuzanna Michalska et al.· International Journal of Inn...· 0 citations
In conclusion, the integration of pharmacogenetics and artificial intelligence has considerable promise for the enhanced, secure, and individualized management of cardiovascular illnesses.
S. Azarkan, Fikret Keleş· Pharmacogenomics (London)· 0 citations
The findings suggest that the digitalization of the pharmaceutical industry and enhanced AI integration hold promise for developing safer and more effective therapeutic strategies, while also identifying obstacles to their widespread adoption and optimal functionality.
K. C. Panda, B. Ravi Kumar, J. Sruti et al.· Reviews on recent clinical t...· 0 citations
Artificial intelligence (AI) is rapidly transforming both pediatric healthcare and everyday childhood experiences. Children with diabetes represent a unique population at the intersection of medical AI, including automated insulin delivery (AID) systems, clinical decision support tools, and predictive glucose monitorin...
Hadel Khalil, Jane L. Lynch, A. Sowan et al.· European Journal of Pediatri...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.